
Overview
Background
I am the lead of the Effective and Efficient Healthcare program at the Centre for the Business and Economics of Health at The University of Queensland. I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.
I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $45 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.
I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology GroupI, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy, Griffith University
Research interests
-
Economic Evaluation of Healthcare Interventions
-
Health Technology Assessment
-
Value-Based Health Care
-
Cancer Economics
-
Medications use and safety
Research impacts
My research has significantly influenced health policy in Australia and internationally and was pivotal in the allocation of almost $1 billion in new drugs and medical technologies in Australia over the past ten years. My research program about evaluating new health technologies using Value of Information/implementation analyses led to a paradigm shift in the economic evaluation of new interventions and improved patient access to health innovations (e.g., genetic testing, targeted therapies). My research shifted the way clinical trials are prioritised and funded towards a value-based approach, which informed the development of the Australian Clinical Trials Alliance Research Prioritisation Framework.
I have published over 100 peer reviewed articles and technical reports for leading organisations, including 45 technical reports for the Australian Government on the economic evaluation of novel drugs, devices and services for a range of conditions including cancer, genetic testing, cardiovascular disease and liver disease.
Works
Search Professor Haitham Tuffaha’s works on UQ eSpace
2014
Journal Article
GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: collection effectiveness and cost effectiveness analysis
Abdel-Rahman, Fawzi, Tuffaha, Haitham W, Sharma, Shanta, Jazar, Husam Abu, Hussein, Nilly, Saad, Adnan, Al Rawi, Omar and Hussein, Ayad (2014). GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: collection effectiveness and cost effectiveness analysis. Journal of Oncology Pharmacy Practice, 20 (2), 130-136. doi: 10.1177/1078155213484785
2014
Journal Article
Value of information analysis in healthcare: a review of principles and applications
Tuffaha, Haitham W., Gordon, Louisa G. and Scuffham, Paul A. (2014). Value of information analysis in healthcare: a review of principles and applications. Journal of Medical Economics, 17 (6), 377-383. doi: 10.3111/13696998.2014.907170
2014
Journal Article
Value of information analysis in oncology: the value of evidence and evidence of value
Tuffaha, Haitham W., Gordon, Louisa G. and Scuffham, Paul A. (2014). Value of information analysis in oncology: the value of evidence and evidence of value. Journal of Oncology Practice, 10 (2), e55-e62. doi: 10.1200/JOP.2013.001108
2014
Journal Article
Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters
Tuffaha, Haitham W., Rickard, Claire M., Webster, Joan, Marsh, Nicole, Gordon, Louisa, Wallis, Marianne and Scuffham, Paul A. (2014). Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters. Applied Health Economics and Health Policy, 12 (1), 51-58. doi: 10.1007/s40258-013-0077-2
2012
Journal Article
Revision and validation of a medication assessment tool for chronic cancer pain management
Salmany, Sewar S., Koopmans, Sara M., Treish, Imad M., El Jaber, Rana, Telfah, Shorouq and Tuffaha, Haitham W. (2012). Revision and validation of a medication assessment tool for chronic cancer pain management. The American Journal of Hospice and Palliative Medicine, 29 (8), 640-646. doi: 10.1177/1049909111435812
2012
Journal Article
Glucarpidase for the treatment of life-threatening methotrexate overdose
Tuffaha, H. W. and Al Omar, S. (2012). Glucarpidase for the treatment of life-threatening methotrexate overdose. Drugs of Today, 48 (11), 705-711. doi: 10.1358/dot.2012.48.11.1871575
2012
Journal Article
Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center
Tuffaha, Haitham W and Koopmans, Sara M (2012). Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center. Journal of Oncology Pharmacy Practice, 18 (2), 180-185. doi: 10.1177/1078155211416529
2012
Conference Publication
THE EFFECTIVENESS AND COST EFFECTIVENESS OF PLERIXAFOR plus GCSF VERSUS GCSF +/- CHEMOTHERAPY AS SALVAGE MOBILIZATION REGIMENS IN LYMPHOMA AND MULTIPLE MYELOMA PATIENTS
Tuffaha, H. W., Hussein, A. A., Sharma, S., Abu-Jazar, H., Al-Rawi, O. S., Saad, A. M., Al-Zaben, A., Hussein, N. and Abdel-Rahman, F. A. (2012). THE EFFECTIVENESS AND COST EFFECTIVENESS OF PLERIXAFOR plus GCSF VERSUS GCSF +/- CHEMOTHERAPY AS SALVAGE MOBILIZATION REGIMENS IN LYMPHOMA AND MULTIPLE MYELOMA PATIENTS. BMT Tandem Meeting, San Diego Ca, Feb 01-05, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.bbmt.2011.12.130
2012
Conference Publication
COMPARATIVE COST UTILITY ANALYSIS OF PLERIXAFOR PLUS GCSF VERSUS CYCLOPHOSPHAMIDE PLUS GCSF AS SALVAGE MOBILIZATION REGIMENS IN MULTIPLE MYELOMA PATIENTS
Tuffaha, H. W., Hussein, A. A. and Abdel-Rahman, F. A. (2012). COMPARATIVE COST UTILITY ANALYSIS OF PLERIXAFOR PLUS GCSF VERSUS CYCLOPHOSPHAMIDE PLUS GCSF AS SALVAGE MOBILIZATION REGIMENS IN MULTIPLE MYELOMA PATIENTS. BMT Tandem Meeting, San Diego Ca, Feb 01-05, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.bbmt.2011.12.132
2012
Journal Article
Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center
Tuffaha, Haitham W., Abdelhadi, Ola and Al Omar, Suha (2012). Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. International Journal of Clinical Pharmacy, 34 (1), 27-31. doi: 10.1007/s11096-011-9600-4
2012
Conference Publication
Adverse drug reactions in bone marrow transplant patients
Najjar, R., Tuffaha, H., Abdel-Rahman, F., Hussein, A. and Jazar, H. A. (2012). Adverse drug reactions in bone marrow transplant patients. 38th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), Geneva, Switzerland, 1-4 April, 2012. London, United Kingdom: Nature Publishing Group. doi: 10.1038/bmt.2012.37
2011
Journal Article
Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity
Tuffaha, Haitham W and Al Omar, Suha (2011). Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity. Journal of Oncology Pharmacy Practice, 17 (2), 136-40. doi: 10.1177/1078155209348720
2010
Journal Article
Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor
Tuffaha, Haitham and Abdel-Rahman, Fawzi Abdel-Latif (2010). Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor. Hematology/ Oncology and Stem Cell Therapy, 3 (4), 203-205. doi: 10.5144/1658-3876.2010.203
2008
Journal Article
The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting
Tuffaha, Haitham W., Treish, Imad M. and Zaru, Luna (2008). The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting. Journal of Oncology Pharmacy Practice, 14 (3), 131-8. doi: 10.1177/1078155208091249
2005
Other Outputs
Implementation and validation of a method for characterising prescribing activity and associated pharmaceutical activity in haematology setting
Tuffaha, Haitham (2005). Implementation and validation of a method for characterising prescribing activity and associated pharmaceutical activity in haematology setting. M.Sc Thesis, School of Pharmacy, University of Strathclyde.
Funding
Current funding
Supervision
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program
Principal Advisor
Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds
-
Doctor Philosophy
Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program
Principal Advisor
Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds
-
Doctor Philosophy
Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment
Principal Advisor
Other advisors: Professor Sandie McCarthy
Completed supervision
-
2024
Doctor Philosophy
Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment
Principal Advisor
Other advisors: Professor Sandie McCarthy
Media
Enquiries
Contact Professor Haitham Tuffaha directly for media enquiries about:
- Cancer Economics
- Health Economics
- Health Services Research
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: